Max Robotics — Global Service Robot Directory + US Certification

About

Giorgia Dinoi is a leading gynecologic oncologist whose research focuses on optimizing surgical outcomes for patients with endometrial cancer, particularly those with high-risk or complex presentations. Her work has been instrumental in comparing minimally invasive techniques—including robotic-assisted and conventional laparoscopic surgery—against traditional open surgery, with a special emphasis on obese patients and those with high-risk disease. In her landmark 2022 cohort study, Dinoi demonstrated that minimally invasive surgery offers comparable oncologic outcomes to open surgery in high-risk endometrial cancer, a finding that has reshaped clinical practice and garnered 18 citations. More recently, her 2024 randomized controlled trial (RObese) provided critical evidence that robotic-assisted surgery is superior to conventional laparoscopy in obese patients with early endometrial cancer, particularly in the sentinel lymph node era. This work, with 16 citations, underscores her commitment to tailoring surgical approaches to patient-specific risk factors. Dinoi’s contributions have advanced the field by providing high-quality data that supports the safety and efficacy of minimally invasive techniques, ultimately improving recovery and quality of life for women with endometrial cancer.